vs
Side-by-side financial comparison of Pediatrix Medical Group, Inc. (MD) and Skyward Specialty Insurance Group, Inc. (SKWD). Click either name above to swap in a different company.
Pediatrix Medical Group, Inc. is the larger business by last-quarter revenue ($493.8M vs $385.6M, roughly 1.3× Skyward Specialty Insurance Group, Inc.). Skyward Specialty Insurance Group, Inc. runs the higher net margin — 11.2% vs 6.8%, a 4.4% gap on every dollar of revenue. On growth, Skyward Specialty Insurance Group, Inc. posted the faster year-over-year revenue change (26.7% vs -1.7%). Over the past eight quarters, Skyward Specialty Insurance Group, Inc.'s revenue compounded faster (20.6% CAGR vs -0.1%).
Pediatrix Medical Group, Inc. is a leading U.S. specialized medical service provider focusing on maternal-fetal care, neonatology, pediatric cardiology and other pediatric subspecialties. It partners with U.S. healthcare facilities to deliver evidence-based care to women, newborns and children.
Skyward Specialty Insurance Group, Inc. is a specialty property and casualty insurance provider offering tailored coverage solutions including commercial auto, general liability, professional indemnity, and specialty property policies. It primarily serves small-to-medium enterprises and niche industry segments across the United States, focusing on underwriting complex, hard-to-place risks for underserved client groups.
MD vs SKWD — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $493.8M | $385.6M |
| Net Profit | $33.7M | $43.2M |
| Gross Margin | — | — |
| Operating Margin | 9.9% | 14.2% |
| Net Margin | 6.8% | 11.2% |
| Revenue YoY | -1.7% | 26.7% |
| Net Profit YoY | 10.5% | 200.1% |
| EPS (diluted) | $0.40 | $1.03 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $493.8M | $385.6M | ||
| Q3 25 | $492.9M | $382.5M | ||
| Q2 25 | $468.8M | $319.9M | ||
| Q1 25 | $458.4M | $328.5M | ||
| Q4 24 | $502.4M | $304.4M | ||
| Q3 24 | $511.2M | $300.9M | ||
| Q2 24 | $504.3M | $279.9M | ||
| Q1 24 | $495.1M | $265.0M |
| Q4 25 | $33.7M | $43.2M | ||
| Q3 25 | $71.7M | $45.9M | ||
| Q2 25 | $39.3M | $38.8M | ||
| Q1 25 | $20.7M | $42.1M | ||
| Q4 24 | $30.5M | $14.4M | ||
| Q3 24 | $19.4M | $36.7M | ||
| Q2 24 | $-153.0M | $31.0M | ||
| Q1 24 | $4.0M | $36.8M |
| Q4 25 | 9.9% | 14.2% | ||
| Q3 25 | 13.8% | 15.8% | ||
| Q2 25 | 12.8% | 15.6% | ||
| Q1 25 | 7.0% | 15.7% | ||
| Q4 24 | 7.8% | 6.1% | ||
| Q3 24 | 6.6% | 15.6% | ||
| Q2 24 | -31.3% | 14.4% | ||
| Q1 24 | 3.2% | 17.7% |
| Q4 25 | 6.8% | 11.2% | ||
| Q3 25 | 14.5% | 12.0% | ||
| Q2 25 | 8.4% | 12.1% | ||
| Q1 25 | 4.5% | 12.8% | ||
| Q4 24 | 6.1% | 4.7% | ||
| Q3 24 | 3.8% | 12.2% | ||
| Q2 24 | -30.3% | 11.1% | ||
| Q1 24 | 0.8% | 13.9% |
| Q4 25 | $0.40 | $1.03 | ||
| Q3 25 | $0.84 | $1.10 | ||
| Q2 25 | $0.46 | $0.93 | ||
| Q1 25 | $0.24 | $1.01 | ||
| Q4 24 | $0.37 | $0.33 | ||
| Q3 24 | $0.23 | $0.89 | ||
| Q2 24 | $-1.84 | $0.75 | ||
| Q1 24 | $0.05 | $0.90 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $375.2M | $168.5M |
| Total DebtLower is stronger | $570.5M | — |
| Stockholders' EquityBook value | $865.9M | $1.0B |
| Total Assets | $2.2B | $4.8B |
| Debt / EquityLower = less leverage | 0.66× | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $375.2M | $168.5M | ||
| Q3 25 | $340.1M | $160.1M | ||
| Q2 25 | $224.7M | $136.6M | ||
| Q1 25 | $99.0M | $112.9M | ||
| Q4 24 | $229.9M | $121.6M | ||
| Q3 24 | $103.8M | $105.6M | ||
| Q2 24 | $19.4M | $73.0M | ||
| Q1 24 | $8.0M | $85.1M |
| Q4 25 | $570.5M | — | ||
| Q3 25 | $577.2M | — | ||
| Q2 25 | $583.9M | — | ||
| Q1 25 | $590.5M | — | ||
| Q4 24 | $597.1M | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | $865.9M | $1.0B | ||
| Q3 25 | $890.7M | $961.4M | ||
| Q2 25 | $833.8M | $899.9M | ||
| Q1 25 | $789.2M | $850.7M | ||
| Q4 24 | $764.9M | $794.0M | ||
| Q3 24 | $732.5M | $797.5M | ||
| Q2 24 | $706.5M | $723.6M | ||
| Q1 24 | $856.2M | $692.3M |
| Q4 25 | $2.2B | $4.8B | ||
| Q3 25 | $2.2B | $4.6B | ||
| Q2 25 | $2.1B | $4.3B | ||
| Q1 25 | $2.0B | $4.0B | ||
| Q4 24 | $2.2B | $3.7B | ||
| Q3 24 | $2.1B | $3.6B | ||
| Q2 24 | $2.0B | $3.4B | ||
| Q1 24 | $2.2B | $3.2B |
| Q4 25 | 0.66× | — | ||
| Q3 25 | 0.65× | — | ||
| Q2 25 | 0.70× | — | ||
| Q1 25 | 0.75× | — | ||
| Q4 24 | 0.78× | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $114.1M | $408.1M |
| Free Cash FlowOCF − Capex | — | $402.6M |
| FCF MarginFCF / Revenue | — | 104.4% |
| Capex IntensityCapex / Revenue | — | 1.4% |
| Cash ConversionOCF / Net Profit | 3.39× | 9.44× |
| TTM Free Cash FlowTrailing 4 quarters | — | $755.2M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $114.1M | $408.1M | ||
| Q3 25 | $137.3M | $171.4M | ||
| Q2 25 | $137.2M | $88.2M | ||
| Q1 25 | $-117.5M | $96.8M | ||
| Q4 24 | $133.0M | $305.1M | ||
| Q3 24 | $91.8M | $168.0M | ||
| Q2 24 | $107.0M | $21.0M | ||
| Q1 24 | $-125.2M | $94.3M |
| Q4 25 | — | $402.6M | ||
| Q3 25 | — | $168.9M | ||
| Q2 25 | — | $87.1M | ||
| Q1 25 | — | $96.6M | ||
| Q4 24 | — | $300.9M | ||
| Q3 24 | — | $167.6M | ||
| Q2 24 | — | $18.4M | ||
| Q1 24 | — | $94.0M |
| Q4 25 | — | 104.4% | ||
| Q3 25 | — | 44.2% | ||
| Q2 25 | — | 27.2% | ||
| Q1 25 | — | 29.4% | ||
| Q4 24 | — | 98.8% | ||
| Q3 24 | — | 55.7% | ||
| Q2 24 | — | 6.6% | ||
| Q1 24 | — | 35.5% |
| Q4 25 | — | 1.4% | ||
| Q3 25 | — | 0.6% | ||
| Q2 25 | — | 0.3% | ||
| Q1 25 | — | 0.1% | ||
| Q4 24 | — | 1.4% | ||
| Q3 24 | — | 0.1% | ||
| Q2 24 | — | 0.9% | ||
| Q1 24 | — | 0.1% |
| Q4 25 | 3.39× | 9.44× | ||
| Q3 25 | 1.91× | 3.73× | ||
| Q2 25 | 3.49× | 2.27× | ||
| Q1 25 | -5.66× | 2.30× | ||
| Q4 24 | 4.36× | 21.18× | ||
| Q3 24 | 4.72× | 4.58× | ||
| Q2 24 | — | 0.68× | ||
| Q1 24 | -31.03× | 2.56× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
MD
| Health Care Patient Service | $421.6M | 85% |
| Hospitals Contracts | $70.0M | 14% |
| Other | $2.2M | 0% |
SKWD
Segment breakdown not available.
